Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center
University of Michigan Rogel Cancer Center
SWOG Cancer Research Network
City of Hope Medical Center
Novartis
Children's Oncology Group
City of Hope Medical Center
City of Hope Medical Center
Fundacion CRIS de Investigación para Vencer el Cáncer
Masaryk University
Il-Yang Pharm. Co., Ltd.
Imperial College Healthcare NHS Trust